Primary Peritoneal Cancer Clinical Trials
3 recruiting trials for Primary Peritoneal Cancer. Eligibility criteria explained in plain English.
3
Total Trials
3
Recruiting Now
0
Phase 3 Trials
3
Sponsors
Recruiting Trials
RECRUITINGNCT05574673
Characterization of Epithelial Ovarian Cancer Patients in Terms of Homologous Recombination Phenotype
This is a prospective observational multi-country, multi-center study of a large real-world cohort of first line (1L) epithelial ovarian cancer patients, exposed to standard of...
Sponsor: Nordic Society of Gynaecological Oncology - Clinical Trials UnitEnrolling: 10001 location
RECRUITINGPhase 2NCT06787612
Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer
This study is researching an experimental drug called ubamatamab, also referred to as "study drug". The study is focused on patients who have advanced ovarian cancer. The aim of...
Sponsor: Regeneron PharmaceuticalsEnrolling: 22020 locations
RECRUITINGPhase 1 / Phase 2NCT05086692
A Beta-only IL-2 ImmunoTherapY Study
This is a Phase 1/2, multi-center, open-label, dose-escalation and expansion study to evaluate safety and tolerability, PK, pharmacodynamic, and early signal of anti-tumor...
Sponsor: Medicenna Therapeutics, Inc.Enrolling: 11520 locations